Home › Funds › NJ State Employees Deferred Compensation Plan › BSX
NJ State Employees Deferred Compensation Plan position in BSX
BOSTON SCIENTIFIC CORP · Health Care
NJ State Employees Deferred Compensation Plan reported holding 43,600 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2025 13F filing — a position valued at US$4.3M, representing 0.47% of its reported portfolio and ranking #42 among its reported holdings. NJ State Employees Deferred Compensation Plan has disclosed BSX holdings in 9 of the last 9 reported quarters, going back to Q3 2023.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How NJ State Employees Deferred Compensation Plan's BSX position evolved
NJ State Employees Deferred Compensation Plan first disclosed a stake in BSX in Q3 2023 at 55,000 shares (US$2.9M). The position peaked in Q2 2025 at 47,000 shares, worth US$5.0M. Across 9 filings, NJ State Employees Deferred Compensation Plan increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2025) shows 43,600 shares valued at US$4.3M — a reduction of -3,400 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 55.00K | $2.90M | New |
| Q4 2023 | 55.00K | $3.18M | Hold |
| Q1 2024 | 55.00K | $3.77M | Hold |
| Q2 2024 | 55.00K | $4.24M | Hold |
| Q3 2024 | 55.00K | $4.61M | Hold |
| Q4 2024 | 47.00K | $4.20M | Reduce |
| Q1 2025 | 47.00K | $4.74M | Hold |
| Q2 2025 | 47.00K | $5.05M | Hold |
| Q3 2025 | 43.60K | $4.26M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- Banque Cantonale Vaudoise 67.61K sh · $2.89B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 50.52M sh · $2.16B · Q2 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
- Bollard Group LLC 18.42M sh · $786.20M · Q2 2026
More on NJ State Employees Deferred Compensation Plan
FAQ
How long has NJ State Employees Deferred Compensation Plan held BSX?
NJ State Employees Deferred Compensation Plan has disclosed BSX holdings in 9 of the last 9 reported quarters, going back to Q3 2023.
What is NJ State Employees Deferred Compensation Plan's current position in BSX?
As of Q3 2025, NJ State Employees Deferred Compensation Plan holds 43.60K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $4.26M, representing 0.47% of its reported portfolio and ranking #42.
Has NJ State Employees Deferred Compensation Plan been buying or selling BSX?
In the latest 13F filing (Q3 2025), NJ State Employees Deferred Compensation Plan reduced its position in BSX. The position peaked in Q2 2025 at 47.00K shares.
Which other funds hold BSX?
Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.